Screening for breast cancer

Stephen W Duffy, Robert A Smith, Rhian Gabe, László Tabár, Amy M F Yen, Tony H H Chen

Research output: Contribution to journalArticlepeer-review


Strong evidence supports the value of breast cancer screening with mammography, and high-quality mammography screening can be considered a major public health achievement. As noted earlier in the discussion about the evaluation of service screening, the group of women who did not participate in mammographic screening in the decades after screening had been introduced had essentially unchanged or only minor improvements in mortality compared with the pattern before the introduction of screening, despite widespread use of adjuvant chemotherapy or hormonal therapy. Breast cancer should be treated in its preclinical phase if we are to save the lives of women with this disease, and a considerable body of evidence outlines best practices that, with broader adherence, would result in greater breast cancer mortality reductions than have been observed to date.
Original languageEnglish
Pages (from-to)671-97
Number of pages27
JournalSurgical oncology clinics of North America
Issue number4
Publication statusPublished - 2005

Cite this